174 related articles for article (PubMed ID: 9423932)
1. Labelling of CRF1 and CRF2 receptors using the novel radioligand, [3H]-urocortin.
Gottowik J; Goetschy V; Henriot S; Kitas E; Fluhman B; Clerc RG; Moreau JL; Monsma FJ; Kilpatrick GJ
Neuropharmacology; 1997 Oct; 36(10):1439-46. PubMed ID: 9423932
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterisation of the recombinant human CRF binding protein using a simple assay.
Ardati A; Gottowik J; Henriot S; Clerc RG; Kilpatrick GJ
J Neurosci Methods; 1998 Mar; 80(1):99-105. PubMed ID: 9606055
[TBL] [Abstract][Full Text] [Related]
3. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
Grigoriadis DE; Liu XJ; Vaughn J; Palmer SF; True CD; Vale WW; Ling N; De Souza EB
Mol Pharmacol; 1996 Sep; 50(3):679-86. PubMed ID: 8794910
[TBL] [Abstract][Full Text] [Related]
4. Human CRF2 alpha and beta splice variants: pharmacological characterization using radioligand binding and a luciferase gene expression assay.
Ardati A; Goetschy V; Gottowick J; Henriot S; Valdenaire O; Deuschle U; Kilpatrick GJ
Neuropharmacology; 1999 Mar; 38(3):441-8. PubMed ID: 10219982
[TBL] [Abstract][Full Text] [Related]
5. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor.
Lewis K; Li C; Perrin MH; Blount A; Kunitake K; Donaldson C; Vaughan J; Reyes TM; Gulyas J; Fischer W; Bilezikjian L; Rivier J; Sawchenko PE; Vale WW
Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7570-5. PubMed ID: 11416224
[TBL] [Abstract][Full Text] [Related]
6. Autoradiographic localization of CRF1 and CRF2 binding sites in adult rat brain.
Primus RJ; Yevich E; Baltazar C; Gallager DW
Neuropsychopharmacology; 1997 Nov; 17(5):308-16. PubMed ID: 9348546
[TBL] [Abstract][Full Text] [Related]
7. Urocortin is the principal ligand for the corticotrophin-releasing factor binding protein in the ovine brain with no evidence for a sauvagine-like peptide.
Baigent SM; Lowry PJ
J Mol Endocrinol; 2000 Feb; 24(1):53-63. PubMed ID: 10656997
[TBL] [Abstract][Full Text] [Related]
8. Cloning and functional pharmacology of two corticotropin-releasing factor receptors from a teleost fish.
Pohl S; Darlison MG; Clarke WC; Lederis K; Richter D
Eur J Pharmacol; 2001 Nov; 430(2-3):193-202. PubMed ID: 11711031
[TBL] [Abstract][Full Text] [Related]
9. Distribution of corticotropin-releasing factor (CRF) receptor binding in the mouse brain using a new, high-affinity radioligand, [
Tan LA; Vaughan JM; Perrin MH; Rivier JE; Sawchenko PE
J Comp Neurol; 2017 Dec; 525(18):3840-3864. PubMed ID: 28842924
[TBL] [Abstract][Full Text] [Related]
10. Urocortins of the South African clawed frog, Xenopus laevis: conservation of structure and function in tetrapod evolution.
Boorse GC; Crespi EJ; Dautzenberg FM; Denver RJ
Endocrinology; 2005 Nov; 146(11):4851-60. PubMed ID: 16037378
[TBL] [Abstract][Full Text] [Related]
11. Cloning and characterization of human urocortin.
Donaldson CJ; Sutton SW; Perrin MH; Corrigan AZ; Lewis KA; Rivier JE; Vaughan JM; Vale WW
Endocrinology; 1996 May; 137(5):2167-70. PubMed ID: 8612563
[TBL] [Abstract][Full Text] [Related]
12. Conformational states of the corticotropin releasing factor 1 (CRF1) receptor: detection, and pharmacological evaluation by peptide ligands.
Hoare SR; Sullivan SK; Pahuja A; Ling N; Crowe PD; Grigoriadis DE
Peptides; 2003 Dec; 24(12):1881-97. PubMed ID: 15127940
[TBL] [Abstract][Full Text] [Related]
13. Functional, endogenously expressed corticotropin-releasing factor receptor type 1 (CRF1) and CRF1 receptor mRNA expression in human neuroblastoma SH-SY5Y cells.
Schoeffter P; Feuerbach D; Bobirnac I; Gazi L; Longato R
Fundam Clin Pharmacol; 1999; 13(4):484-9. PubMed ID: 10456290
[TBL] [Abstract][Full Text] [Related]
14. Monkey corticotropin-releasing factor1 receptor: Complementary DNA cloning and pharmacological characterization.
Oshida Y; Ikeda Y; Chaki S; Okuyama S
Life Sci; 2004 Feb; 74(15):1911-24. PubMed ID: 14761672
[TBL] [Abstract][Full Text] [Related]
15. Characterisation using microphysiometry of CRF receptor pharmacology.
Smart D; Coppell A; Rossant C; Hall M; McKnight AT
Eur J Pharmacol; 1999 Aug; 379(2-3):229-35. PubMed ID: 10497910
[TBL] [Abstract][Full Text] [Related]
16. The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist.
Baram TZ; Chalmers DT; Chen C; Koutsoukos Y; De Souza EB
Brain Res; 1997 Oct; 770(1-2):89-95. PubMed ID: 9372207
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the corticotropin-releasing factor (CRF) type 2 receptor in CRF-induced thyrotropin release by the amphibian pituitary gland.
Okada R; Miller MF; Yamamoto K; De Groef B; Denver RJ; Kikuyama S
Gen Comp Endocrinol; 2007 Feb; 150(3):437-44. PubMed ID: 17188689
[TBL] [Abstract][Full Text] [Related]
18. Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: the CRF2gamma receptor.
Kostich WA; Chen A; Sperle K; Largent BL
Mol Endocrinol; 1998 Aug; 12(8):1077-85. PubMed ID: 9717834
[TBL] [Abstract][Full Text] [Related]
19. Modulation of Ca2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells.
Kageyama K; Kimura R; Suga S; Ogawa Y; Suda T; Wakui M
Peptides; 2006 Jul; 27(7):1814-9. PubMed ID: 16513211
[TBL] [Abstract][Full Text] [Related]
20. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor.
Vaughan J; Donaldson C; Bittencourt J; Perrin MH; Lewis K; Sutton S; Chan R; Turnbull AV; Lovejoy D; Rivier C
Nature; 1995 Nov; 378(6554):287-92. PubMed ID: 7477349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
